Integration of Immune Effector Cellular Therapy into a FACT-Accredited Transplant Program presented by Dr. Carlos Bachier
In This Issue
- Just the FACTs, Volume 3
- FACT COVID-19 Resources
- United States Food and Drug Administration Issues Guidance on COVID-19 Convalescent Plasma
- New Product Description Codes for Convalescent Plasma COVID-19
- Integration of Immune Effector Cellular Therapy into a FACT-Accredited Transplant Program presented by Dr. Carlos Bachier
- Canceled: FACT Cellular Therapy Collection Inspection and Accreditation Workshop
- Canceled: FACT Cord Blood Inspection and Accreditation Workshop at ISCT Annual Meeting
- FACT Cord Blood Inspection and Accreditation Workshop at the 2020 Cord Blood Connect International Congress on Hold
Accreditation Statistics
As of August 1, 2022
Cellular Therapy Entities
- Accredited: 250
- Applicants: 25
Cord Blood Banks
- Accredited: 56
- Applicants: 7
Congratulations to the following program for achieving initial FACT accreditation: King Abdulaziz Medical City - Riyadh, Saudi Arabia (adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy; marrow and peripheral blood cellular therapy product collection; cellular therapy product processing with minimal manipulation). A complete list of accredited organizations can be found at www.factwebsite.org.
